Survivorship: Sleep Disorders, Version 1.2014

Restricted access

Sleep disorders, including insomnia and excessive sleepiness, affect a significant proportion of patients with cancer and survivors, often in combination with fatigue, anxiety, and depression. Improvements in sleep lead to improvements in fatigue, mood, and quality of life. This section of the NCCN Guidelines for Survivorship provides screening, diagnosis, and management recommendations for sleep disorders in survivors. Management includes combinations of sleep hygiene education, physical activity, psychosocial interventions, and pharmacologic treatments.

  • 1.

    Berger AM, Mitchell SA. Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw 2008;6:313.

  • 2.

    Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 2001;10:245255.

    • Search Google Scholar
    • Export Citation
  • 3.

    Ancoli-Israel S. Recognition and treatment of sleep disturbances in cancer. J Clin Oncol 2009;27:58645866.

  • 4.

    Carney S, Koetters T, Cho M. Differences in sleep disturbance parameters between oncology outpatients and their family caregivers. J Clin Oncol 2011;29:10011006.

    • Search Google Scholar
    • Export Citation
  • 5.

    Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev 2006;10:419429.

  • 6.

    Fiorentino L, Ancoli-Israel S. Sleep dysfunction in patients with cancer. Curr Treat Options Neurol 2007;9:337346.

  • 7.

    Flynn KE, Shelby RA, Mitchell SA. Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). Psychooncology 2010;19:10861093.

    • Search Google Scholar
    • Export Citation
  • 8.

    Forsythe LP, Helzlsouer KJ, MacDonald R, Gallicchio L. Daytime sleepiness and sleep duration in long-term cancer survivors and non-cancer controls: results from a registry-based survey study. Support Care Cancer 2012;20:24252432.

    • Search Google Scholar
    • Export Citation
  • 9.

    Liu L, Ancoli-Israel S. Sleep disturbances in cancer. Psychiatr Ann 2008;38:627634.

  • 10.

    Zee PC, Ancoli-Israel S. Does effective management of sleep disorders reduce cancer-related fatigue? Drugs 2009;69 (Suppl 2):2941.

  • 11.

    Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 2008;61:664675.

    • Search Google Scholar
    • Export Citation
  • 12.

    Palesh O, Aldridge-Gerry A, Ulusakarya A. Sleep disruption in breast cancer patients and survivors. J Natl Compr Canc Netw 2013;11:15231530.

    • Search Google Scholar
    • Export Citation
  • 13.

    Omachi TA. Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S287296.

    • Search Google Scholar
    • Export Citation
  • 14.

    Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology 2005;14:429441.

  • 15.

    Chung F, Yegneswaran B, Liao P. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108:812821.

  • 16.

    Silva GE, Vana KD, Goodwin JL. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOP-Bang, and Epworth Sleepiness Scales. J Clin Sleep Med 2011;7:467472.

    • Search Google Scholar
    • Export Citation
  • 17.

    Buchfuhrer MJ. Strategies for the treatment of restless legs syndrome. Neurotherapeutics 2012;9:776790.

  • 18.

    Moyer DE, Zayas-Bazan J, Reese G. Restless legs syndrome: diagnostic time-savers, Tx tips. J Fam Pract 2009;58:415423.

  • 19.

    Antonescu-Turcu A, Parthasarathy S. CPAP and bi-level PAP therapy: new and established roles. Respir Care 2010;55:12161229.

  • 20.

    Ballard RD. Management of patients with obstructive sleep apnea. J Fam Pract 2008;57:S2430.

  • 21.

    Weingarten JA, Basner RC. Advances in the management of adult obstructive sleep apnea. F1000 Med Rep 2009;1.

  • 22.

    Bassetti CL, Bornatico F, Fuhr P. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial. Swiss Med Wkly 2011;141:w13274.

    • Search Google Scholar
    • Export Citation
  • 23.

    Ferini-Strambi L, Aarskog D, Partinen M. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med 2008;9:874881.

    • Search Google Scholar
    • Export Citation
  • 24.

    Kaplan PW, Allen RP, Buchholz DW, Walters JK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993;16:717723.

    • Search Google Scholar
    • Export Citation
  • 25.

    Manconi M, Ferri R, Zucconi M. Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome. Mov Disord 2011;26:892895.

    • Search Google Scholar
    • Export Citation
  • 26.

    Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938943.

    • Search Google Scholar
    • Export Citation
  • 27.

    Oertel WH, Stiasny-Kolster K, Bergtholdt B. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Mov Disord 2007;22:213219.

    • Search Google Scholar
    • Export Citation
  • 28.

    Trenkwalder C, Garcia-Borreguero D, Montagna P. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75:9297.

    • Search Google Scholar
    • Export Citation
  • 29.

    Walters AS, Ondo WG, Dreykluft T. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebocontrolled study. Mov Disord 2004;19:14141423.

    • Search Google Scholar
    • Export Citation
  • 30.

    Wilt TJ, MacDonald R, Ouellette J. Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis. JAMA Intern Med 2013;173:496505.

    • Search Google Scholar
    • Export Citation
  • 31.

    Hornyak M, Scholz H, Kohnen R. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Sleep Med Rev 2013.

    • Search Google Scholar
    • Export Citation
  • 32.

    Morgenthaler T, Kramer M, Alessi C. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 2006;29:14151419.

    • Search Google Scholar
    • Export Citation
  • 33.

    Morgenthaler TI, Kapur VK, Brown T. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007;30:17051711.

    • Search Google Scholar
    • Export Citation
  • 34.

    Insomnia: assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia. Am Fam Physician 1999;59:30293038.

    • Search Google Scholar
    • Export Citation
  • 35.

    Kupfer DJ, Reynolds CF 3rd. Management of insomnia. N Engl J Med 1997;336:341346.

  • 36.

    Lippmann S, Mazour I, Shahab H. Insomnia: therapeutic approach. South Med J 2001;94:866873.

  • 37.

    Cheville AL, Kollasch J, Vandenberg J. A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage 2013;45:811821.

    • Search Google Scholar
    • Export Citation
  • 38.

    Mishra SI, Scherer RW, Geigle PM. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev 2012;8:CD007566.

    • Search Google Scholar
    • Export Citation
  • 39.

    Mishra SI, Scherer RW, Snyder C. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012;8:CD008465.

    • Search Google Scholar
    • Export Citation
  • 40.

    Mustian KM, Sprod LK, Janelsins M. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 2013;31:32333241.

    • Search Google Scholar
    • Export Citation
  • 41.

    Payne JK, Held J, Thorpe J, Shaw H. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 2008;35:635642.

    • Search Google Scholar
    • Export Citation
  • 42.

    Rogers LQ, Fogleman A, Trammell R. Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther 2013;12:323335.

    • Search Google Scholar
    • Export Citation
  • 43.

    Van Gerpen RE, Becker BJ. Development of an evidence-based exercise and education cancer recovery program. Clin J Oncol Nurs 2013;17:539543.

    • Search Google Scholar
    • Export Citation
  • 44.

    Bootzin RR, Perlis ML. Nonpharmacologic treatments of insomnia. J Clin Psychiatry 1992;53(Suppl):3741.

  • 45.

    Espie CA, Fleming L, Cassidy J. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008;26:46514658.

    • Search Google Scholar
    • Export Citation
  • 46.

    Epstein DR, Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum 2007;34:E5159.

    • Search Google Scholar
    • Export Citation
  • 47.

    Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006;24:48824887.

    • Search Google Scholar
    • Export Citation
  • 48.

    Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 2005;23:60836096.

    • Search Google Scholar
    • Export Citation
  • 49.

    Nakamura Y, Lipschitz DL, Kuhn R. Investigating efficacy of two brief mind-body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial. J Cancer Surviv 2013;7:165182.

    • Search Google Scholar
    • Export Citation
  • 50.

    National Institutes of Health. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005;28:10491057.

    • Search Google Scholar
    • Export Citation
  • 51.

    Neubauer DN. The evolution and development of insomnia pharmacotherapies. J Clin Sleep Med 2007;3:S1115.

  • 52.

    Kim SW, Shin IS, Kim JM. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci 2008;62:7583.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 162 97 5
PDF Downloads 36 27 2
EPUB Downloads 0 0 0